Publications by authors named "G Kalyatanda"

is a slow-growing nontuberculous mycobacterium (NTM) requiring prolonged treatment with multiple antimicrobials. It primarily affects immunocompromised patients and causes infection of the respiratory tract, skin, and soft tissue. While enteric carriage of has been reported, it has not been associated with clinical infection in immunocompetent hosts.

View Article and Find Full Text PDF

In 2020, it was estimated that there were 155 million survivors of TB alive, all at risk of possible post TB disability. The 2 International Post-Tuberculosis Symposium (Stellenbosch, South Africa) was held to increase global awareness and empower TB-affected communities to play an active role in driving the agenda. We aimed to update knowledge on post-TB life and illness, identify research priorities, build research collaborations and highlight the need to embed lung health outcomes in clinical TB trials and programmatic TB care services.

View Article and Find Full Text PDF

Non-tuberculous mycobacteria (NTM) are slow-growing opportunistic pathogens that cause a variety of cutaneous, soft tissue, and pulmonary infections. On rare occasions, NTM causes chronic rhinosinusitis, with the majority of cases presenting in immunocompromised individuals. Other potential risk factors include the presence of foreign bodies, previous sinus surgery or chemoradiation, and use of contaminated water in sinus rinses.

View Article and Find Full Text PDF

A variety of gram-positive infections can be treated with daptomycin. Daptomycin-induced acute eosinophilic pneumonia (DEP) is a rare adverse drug reaction with nonspecific clinical findings of dyspnea, dry cough, and fever. Although diagnostic criteria exist, prompt recognition is important to prevent rapid progression and respiratory failure.

View Article and Find Full Text PDF